Cargando…
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future
This review will summarize and synthesize recent findings in regard to monogenic kidney disorders, including how that evidence is being translated into practice. It will add to existing key knowledge to provide context for clinicians in consolidating existing practice and approaches. RECENT FINDINGS...
Autor principal: | Mallett, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594128/ https://www.ncbi.nlm.nih.gov/pubmed/36093902 http://dx.doi.org/10.1097/MNH.0000000000000836 |
Ejemplares similares
-
Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease
por: Humalda, Jelmer K., et al.
Publicado: (2014) -
Safety of intravenous iron use in chronic kidney disease
por: Kalra, Philip A., et al.
Publicado: (2016) -
Plasma and urine biomarkers in chronic kidney disease: closer to clinical application
por: Zabetian, Azadeh, et al.
Publicado: (2021) -
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?
por: Castle, Ellen M., et al.
Publicado: (2023) -
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker
por: Malik, Afshan N.
Publicado: (2023)